Shockwave Medical to Participate in the Bank of America Securities 2021 Health Care Conference

Go back to Shockwave Medical to Participate in the Bank of America Securities 2021 Health Care Conference

NTAP Proposed for C2 in Coronary 'A Win' for Shockwave Medical (SWAV) - Canaccord Genuity

April 28, 2021 10:40 AM EDT

Canaccord Genuity analyst William Plovanic reiterated a Buy rating and $149.00 price target on Shockwave Medical (NASDAQ: SWAV), saying the proposed use of New Technology Add-On Payment (NTAP) for coronary IVL cases by the The Centers for Medicare and Medicaid Services... More